CERO - CERO THERAPEUTICS HOLDINGS, INC.
0.0951
-1.695 -1,782.229%
Share volume: 45,096,838
Last Updated: 10-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.79
-1.69
-0.95%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-14-2024 | 11-20-2024 | 05-15-2025 | 11-19-2025 | |
| Assets | |||||
| Total Assets | 7.371 M | 6.492 M | 7.991 M | 3.911 M | |
| Current Assets | 4.246 M | 3.714 M | 5.768 M | 2.554 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.647 M | 3.380 M | 0.000 | 2.022 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 738.755 K | 624.900 K | 452.227 K | 313.452 K | |
| Other Assets | 2.386 M | 2.153 M | 1.771 M | 1.044 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 7.371 M | 6.492 M | 7.991 M | 3.911 M | |
| Total liabilities | 9.853 M | 10.194 M | 8.321 M | 8.455 M | |
| Total current liabilities | 8.779 M | 9.423 M | 7.859 M | 8.455 M | |
| Accounts Payable | 6.347 M | 6.667 M | 6.379 M | 7.077 M | |
| Other liabilities | 1.021 M | 801.525 K | 85.500 K | 85.500 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.021 M | 801.525 K | 85.500 K | 85.500 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -11.922 M | -7.285 M | -2.757 M | -13.242 M | |
| Common stock | 57.635 M | 66.378 M | 73.346 M | 73.056 M | |
| Retained earnings | -67.362 M | -71.590 M | -76.024 M | -86.297 M |